Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Central nervous system lymphoma

Recruiting

Registered drugNo placebo

Study of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Rituximab

Contact Research Centre

Central nervous system lymphoma

Recruiting

Registered drugNo placebo

Study of Lisocabtagene Maraleucel as First Treatment for Adults with Primary Central Nervous System Lymphoma Who Cannot Have a Stem Cell Transplant

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Calcium Folinate

Contact Research Centre

Central nervous system lymphoma+1

Recruiting

Registered drugNo placebo

Study of Epcoritamab, Lenalidomide, and Rituximab for Patients with Relapsed and Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Epcoritamab

Contact Research Centre

Central nervous system lymphoma+4

Recruiting

Registered drugNo placebo

Study on Golcadomide and Valemetostat Tosylate for Patients with Relapsed or Refractory Non-Hodgkin Lymphomas

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Golcadomide

Contact Research Centre

Central nervous system lymphoma+1

Recruiting

Registered drugNo placebo

Study on the Safety of CA-4948 and Ibrutinib for Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Emavusertib

Contact Research Centre

Central nervous system lymphoma

Not yet recruiting

Registered drugNo placebo

Study on the Effectiveness of Etoposide Phosphate, Carboplatin, Methotrexate, Rituximab, and Cyclophosphamide in Patients with Primary Central Nervous System Lymphoma

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Central nervous system lymphoma

Not recruiting

Registered drugNo placebo

Study on De-escalated Induction Therapy with Methotrexate, Cytarabine, Thiotepa, and Rituximab for Newly Diagnosed Primary CNS Lymphoma Patients

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Busulfan

Contact Research Centre

Central nervous system lymphoma

Not recruiting

Registered drugNo placebo

Study on [18F]-Fludarabine and Gadoteric Acid for Imaging in Patients with Newly Diagnosed Primary CNS Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Gadoteric Acid

Contact Research Centre

Central nervous system lymphoma

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of Berubicin for Patients with Central Nervous System Lymphomas

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Berubicin Hydrochloride

Contact Research Centre

Central nervous system lymphoma

Not recruiting

Registered drugNo placebo

Study on Methotrexate, Tafasitamab, Lenalidomide, and Rituximab for Patients with Primary Central Nervous System Lymphoma Not Eligible for Stem Cell Transplant

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Find therapies in clinical trials near you

10 trials match your criteria

Central nervous system lymphoma

Study of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma

Central nervous system lymphoma

Study of Lisocabtagene Maraleucel as First Treatment for Adults with Primary Central Nervous System Lymphoma Who Cannot Have a Stem Cell Transplant

Central nervous system lymphoma+1

Study of Epcoritamab, Lenalidomide, and Rituximab for Patients with Relapsed and Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Central nervous system lymphoma+4

Study on Golcadomide and Valemetostat Tosylate for Patients with Relapsed or Refractory Non-Hodgkin Lymphomas

Central nervous system lymphoma+1

Study on the Safety of CA-4948 and Ibrutinib for Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Central nervous system lymphoma

Study on the Effectiveness of Etoposide Phosphate, Carboplatin, Methotrexate, Rituximab, and Cyclophosphamide in Patients with Primary Central Nervous System Lymphoma

Central nervous system lymphoma

Study on De-escalated Induction Therapy with Methotrexate, Cytarabine, Thiotepa, and Rituximab for Newly Diagnosed Primary CNS Lymphoma Patients

Central nervous system lymphoma

Study on [18F]-Fludarabine and Gadoteric Acid for Imaging in Patients with Newly Diagnosed Primary CNS Lymphoma

Central nervous system lymphoma

Study on the Safety and Effectiveness of Berubicin for Patients with Central Nervous System Lymphomas

Central nervous system lymphoma

Study on Methotrexate, Tafasitamab, Lenalidomide, and Rituximab for Patients with Primary Central Nervous System Lymphoma Not Eligible for Stem Cell Transplant

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.